Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
myo-inositol + l-arginine + l-carnitine + folic acid
- Development stage
- Unknown
- Lead developer
- Saltvae Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Myo-inositol + L-Arginine + L-Carnitine + Folic Acid is a multi-ingredient nutraceutical formulation manufactured by Saltvae Pharmaceuticals, primarily indicated for the management of polycystic ovary syndrome (PCOS) and female infertility. The combination works synergistically to address metabolic and reproductive dysfunctions: myo-inositol acts as an insulin sensitizer to improve ovulatory function; L-arginine serves as a precursor for nitric oxide synthesis, enhancing pelvic blood flow; L-carnitine supports mitochondrial energy metabolism and oocyte quality; and folic acid is essential for DNA synthesis and reproductive health. The product is typically formulated as an oral tablet and is marketed as a dietary supplement rather than a prescription pharmaceutical.
- Other names
- myo-inositol + l-arginine + l-carnitine + folic acid + selenium
02
Targets
NOS1 (nNOS)INSR (Insulin receptor)DNACPT1A (Carnitine palmitoyltransferase 1A)
Beyond the preview
Go deeper on myo-inositol + l-arginine + l-carnitine + folic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on myo-inositol + l-arginine + l-carnitine + folic acid.